Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
11.7M
-
Shares change
-
+16.9K
-
Total reported value, excl. options
-
$35M
-
Value change
-
+$50.9K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$3.00
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2019
10 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q2 2019.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.7M shares
of 139M outstanding shares and own 8.38% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (9.21M shares), Park West Asset Management LLC (1.26M shares), Telemetry Investments, L.L.C. (782K shares), VANGUARD GROUP INC (284K shares), RENAISSANCE TECHNOLOGIES LLC (74.7K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (50K shares), BlackRock Inc. (11K shares), MORGAN STANLEY (10.2K shares), Winslow, Evans & Crocker, Inc. (1.26K shares), and ROYAL BANK OF CANADA (306 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.